This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 98/7/931    most recent 01.RES.0000216858.04599.e1v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cogolludo, A. Articles by Perez-Vizcaino, F. Search for Related Content PubMed PubMed Citation Articles by Cogolludo, A. Articles by Perez-Vizcaino, F. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Related Collections Cell signalling/signal transduction Ion channels/membrane transport Pulmonary biology and circulation Pulmonary circulation and disease Related Article

(Circulation Research. 2006;98:931.)
© 2006 American Heart Association, Inc.

Cellular Biology

Serotonin Inhibits Voltage-Gated K⁺ Currents in Pulmonary Artery Smooth Muscle Cells

Role of 5-HT_2A Receptors, Caveolin-1, and K_V1.5 Channel Internalization

Angel Cogolludo, Laura Moreno, Federica Lodi, Giovanna Frazziano, Laura Cobeño, Juan Tamargo, Francisco Perez-Vizcaino

From the Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain.

Correspondence to Angel Cogolludo, Department Pharmacology, School Medicine, Universidad Complutense, 28040 Madrid, Spain. E-mail acogolludo{at}ift.csic.es

Multiple lines of evidence indicate that serotonin (5-hydroxytryptamine [5-HT]) and voltage-gated K⁺ (K_V) channels play a central role in the pathogenesis of pulmonary hypertension (PH). We hypothesized that 5-HT might modulate the activity of K_V channels, therefore establishing a link between these pathogenetic factors in PH. Here, we studied the effects of 5-HT on K_V channels present in rat pulmonary artery smooth muscle cells (PASMC) and on hK_V1.5 channels stably expressed in Ltk^– cells. 5-HT reduced native K_V and hK_V1.5 currents, depolarized cell membrane, and caused a contraction of isolated pulmonary arteries. The effects of 5-HT on K_V currents and contraction were markedly prevented by the 5-HT_2A receptor antagonist ketanserin. Incubation with inhibitors of phospholipase C (U73122), classic protein kinase Cs (Gö6976), or tyrosine kinases (genistein and tyrphostin 23), the cholesterol depletion agent ß-cyclodextrin or concanavalin A, an inhibitor of endocytotic processes, also prevented the effects of 5-HT. In homogenates from pulmonary arteries, 5-HT_2A receptors and caveolin-1 coimmunoprecipitated with K_V1.5 channels, and this was increased on stimulation with 5-HT. Moreover, K_V1.5 channels were internalized when cells were stimulated with 5-HT, and this was prevented by concanavalin A. These findings indicate that activation of 5-HT_2A receptors inhibits native K_V and hK_V1.5 currents via phospholipase C, protein kinase C, tyrosine kinase, and a caveolae pathway. K_V channel inhibition accounts, at least partly, for 5-HT-induced pulmonary vasoconstriction and might play a role in PH.

Key Words: potassium ion channels hypertension • pulmonary arteries • receptors

Related Article:

Serotonin-Induced Inhibition of K_V Current: A Supporting Role in Pulmonary Vasoconstriction?

Anthony Varghese, Zhigang Hong, and Edward Kenneth Weir
Circ. Res. 2006 98: 860-862. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				N. W. Morrell, S. Adnot, S. L. Archer, J. Dupuis, P. Lloyd Jones, M. R. MacLean, I. F. McMurtry, K. R. Stenmark, P. A. Thistlethwaite, N. Weissmann, et al. Cellular and Molecular Basis of Pulmonary Arterial Hypertension J. Am. Coll. Cardiol., June 30, 2009; 54(1_Suppl_S): S20 - S31. [Abstract] [Full Text] [PDF]

				R. D. Rainbow, R. I. Norman, D. E. Everitt, J. L. Brignell, N. W. Davies, and N. B. Standen Endothelin-I and angiotensin II inhibit arterial voltage-gated K+ channels through different protein kinase C isoenzymes Cardiovasc Res, June 5, 2009; (2009) cvp143v2. [Abstract] [Full Text] [PDF]

				A. Cogolludo, L. Moreno, G. Frazziano, J. Moral-Sanz, C. Menendez, J. Castaneda, C. Gonzalez, E. Villamor, and F. Perez-Vizcaino Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction Cardiovasc Res, May 1, 2009; 82(2): 296 - 302. [Abstract] [Full Text] [PDF]

				K. D. Luykenaar, R. A. El-Rahman, M. P. Walsh, and D. G. Welsh Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H917 - H926. [Abstract] [Full Text] [PDF]

				J. G. Lopez-Lopez, J. Moral-Sanz, G. Frazziano, M. J. Gomez-Villalobos, J. Flores-Hernandez, E. Monjaraz, A. Cogolludo, and F. Perez-Vizcaino Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L727 - L732. [Abstract] [Full Text] [PDF]

				R. Vicente, N. Villalonga, M. Calvo, A. Escalada, C. Solsona, C. Soler, M. M. Tamkun, and A. Felipe Kv1.5 Association Modifies Kv1.3 Traffic and Membrane Localization J. Biol. Chem., March 28, 2008; 283(13): 8756 - 8764. [Abstract] [Full Text] [PDF]

				D. P. McEwen, Q. Li, S. Jackson, P. M. Jenkins, and J. R. Martens Caveolin Regulates Kv1.5 Trafficking to Cholesterol-Rich Membrane Microdomains Mol. Pharmacol., March 1, 2008; 73(3): 678 - 685. [Abstract] [Full Text] [PDF]

				E. K. Weir, M. Obreztchikova, and Z. Hong Fenfluramine: riddle or Rosetta stone? Eur. Respir. J., February 1, 2008; 31(2): 232 - 235. [Full Text] [PDF]

				S. L. Archer, M. Gomberg-Maitland, M. L. Maitland, S. Rich, J. G. N. Garcia, and E. K. Weir Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1{alpha}-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H570 - H578. [Abstract] [Full Text] [PDF]

				L. Moreno, G. Frazziano, A. Cogolludo, L. Cobeno, J. Tamargo, and F. Perez-Vizcaino Role of Protein Kinase C{zeta} and Its Adaptor Protein p62 in Voltage-Gated Potassium Channel Modulation in Pulmonary Arteries Mol. Pharmacol., November 1, 2007; 72(5): 1301 - 1309. [Abstract] [Full Text] [PDF]

				M. Koide, P. L. Penar, B. I. Tranmer, and G. C. Wellman Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1750 - H1759. [Abstract] [Full Text] [PDF]

				P. B. Sehgal and S. Mukhopadhyay Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H77 - H85. [Abstract] [Full Text] [PDF]

				M. Sanchez, F. Lodi, R. Vera, I. C. Villar, A. Cogolludo, R. Jimenez, L. Moreno, M. Romero, J. Tamargo, F. Perez-Vizcaino, et al. Quercetin and Isorhamnetin Prevent Endothelial Dysfunction, Superoxide Production, and Overexpression of p47phox Induced by Angiotensin II in Rat Aorta J. Nutr., April 1, 2007; 137(4): 910 - 915. [Abstract] [Full Text] [PDF]

				M. de Caestecker Serotonin Signaling in Pulmonary Hypertension Circ. Res., May 26, 2006; 98(10): 1229 - 1231. [Full Text] [PDF]

				A. Varghese, Z. Hong, and E. K. Weir Serotonin-Induced Inhibition of KV Current: A Supporting Role in Pulmonary Vasoconstriction? Circ. Res., April 14, 2006; 98(7): 860 - 862. [Full Text] [PDF]